Skip to main content

Stryker LFIT V40 Femoral Head Trials

Stryker LFIT V40 Femoral Head Trials

Stryker LFIT V40 Femoral Head Trials

Introduction

The Stryker LFit v40 lawsuits centralized along with other hip replacement lawsuits before U.S. District Judge Indira Talwani in the U.S. District Court for the District of Massachusetts in April 2017 as a part of multidistrict litigation No. 2768 are in the pre-trial discovery phase and are maintaining a steady pace.

Recently Judge Talwani called on the plaintiffs and defendants to select nine cases each, for a total of 18, to be a part of the initial bellwether discovery pool on or before February 2, 2018. Cases have to be selected on the basis that they were filed on or before December 12, 2017, and a "substantially completed" Plaintiffs' Fact Sheet has been served by the plaintiff on or before January 12, 2018. The judge also informed the parties to submit proposals regarding how many of the 18 bellwether cases will be eligible for the initial trial pool in September 2018. The first set of cases is expected to go before a jury on September 16, 2019.

The Stryker LFit v40 was removed from the market when reports involving complications and failures including taper lock problems came forth. The complaints received pointed that the metals used, a combination of cobalt-chromium and titanium alloy could lead to fretting and corrosion due to the friction placed upon them when the patient's hip joint moved, resulting in pain, inflammation, loss of mobility, disassociation, and the need for a risky revision surgery. Plaintiffs allege the company knew the device was dangerous and failed to ensure the implants worked together safely and properly with the other components. The final bellwether trial cases will be selected by October 5, 2018.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!